CAH

Cardinal Health
D

CAH

Arincen75/100B
271.74
USD
3.96
(1.48%)
Post Trading·270.81USD-0.93(-0.34%)
Last updated: · Delayed 15 min
Fair value327.68Plus-17%246Price 271.74410
Q1 FY2027 results
EPS3.26+10.9%Revenue67.51B+1.3%
OverviewFinancialsForecastEarningsDividendsCompany

Cardinal Health net income 1986–2027

Cardinal Health earned 554.00M USD in Q1 FY2027, the three months to 30 September 2026, up 23.1% on the same quarter a year before. Cardinal Health's net income over the last twelve months was 1.82B USD, up 14.0% on the twelve months before. In fiscal year 2026 it earned 1.71B USD, up 9.8% on the year before.

Last updated 7 Nov 2026 · Next report 4 Feb 2027

Net income

Net income · +1.8% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20261.82B+13.98%0.71%257.75B
FY202630 Jun 20261.71B+9.80%0.67%254.25B
FY202530 Jun 20251.56B+83.22%0.70%222.58B
FY202430 Jun 2024852.00M+158.18%0.38%226.83B
FY202330 Jun 2023330.00M—0.16%204.98B
FY202230 Jun 2022-938.00M-253.52%-0.52%181.33B
FY202130 Jun 2021611.00M—0.38%162.47B
FY202030 Jun 2020-3.69B-370.95%-2.41%152.92B
FY201930 Jun 20191.36B+432.42%0.94%145.53B
FY201830 Jun 2018256.00M-80.12%0.19%136.81B
FY201730 Jun 20171.29B-9.74%0.99%129.98B
FY201630 Jun 20161.43B+17.45%1.17%121.55B
FY201530 Jun 20151.22B+4.20%1.19%102.53B
FY201430 Jun 20141.17B+249.10%1.28%91.08B
FY201330 Jun 2013334.00M-68.76%0.33%101.09B
FY201230 Jun 20121.07B+11.47%0.99%107.55B
FY201130 Jun 2011959.00M+49.33%0.93%102.64B
FY201030 Jun 2010642.20M-44.23%0.65%98.50B
FY200930 Jun 20091.15B-11.46%1.20%95.99B
FY200830 Jun 20081.30B-32.65%1.49%87.41B
FY200730 Jun 20071.93B+93.09%2.22%86.85B
FY200630 Jun 20061.00B-4.82%1.26%79.66B
FY200530 Jun 20051.05B-28.74%1.45%72.67B
FY200430 Jun 20041.47B+4.89%2.29%64.52B
FY200330 Jun 20031.41B+33.10%2.48%56.73B
FY200230 Jun 20021.06B+23.19%2.07%51.14B
FY200130 Jun 2001857.40M+26.14%1.79%47.95B
FY200030 Jun 2000679.70M+48.96%1.77%38.35B
FY199930 Jun 1999456.30M+84.66%1.82%25.11B
FY199830 Jun 1998247.10M+36.44%1.17%21.08B
FY199730 Jun 1997181.10M+61.84%0.98%18.39B
FY199630 Jun 1996111.90M+31.65%1.21%9.25B
FY199530 Jun 199585.00M+142.17%1.02%8.34B
FY199430 Jun 199435.10M+4.46%0.61%5.79B
FY199330 Jun 199333.60M+33.33%1.71%1.97B
FY199230 Jun 199225.20M+44.83%1.53%1.65B
FY199130 Jun 199117.40M+35.94%1.47%1.18B
FY199030 Jun 199012.80M+45.45%1.46%873.90M
FY198931 Mar 19898.80M+33.33%1.26%700.40M
FY198831 Mar 19886.60M+22.22%1.26%524.60M
FY198731 Mar 19875.40M-10.00%0.83%652.30M
FY198631 Mar 19866.00M—1.40%429.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Cardinal Health's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.